Mar 1, 2026 Log in

News

【Adimmune】March 2026 Revenue NT$65 Million (YoY +2102.7%)

Citation-Grade Primary-source linked Schema.org verified NQ 5 / 100

Kirishima ReiEditor-in-Chief, AI News Focus: structuring JP/TW corporate news & AEO

Published Mar 1, 2026 9:00 AM ・ Updated Jun 1, 2026 1:10 PM ・ 2 min read ・ Source: PR Times

Show contents

⚡ Key Points

Adimmune's revenue for March 2026 was NT$65 million, a staggering increase of +2102.7% year-over-year.
The company is in the Biotechnology and Medical Care industry.

Adimmune's revenue for March 2026 was NT$65 million, a staggering increase of +2102.7% year-over-year. The company is in the Biotechnology and Medical Care industry.

PRIMARY SOURCE Original source: https://openapi.twse.com.tw/revenue/twse-rev-4142-11503 Distributor: PR Times
Published: Mar 1, 2026

Company Ticker: 4142 Company Name: Adimmune Industry: Biotechnology and Medical Care Data Month: 2026-03 Monthly Revenue: 65,485 thousand TWD (65 million) Year-over-Year Change: +2102.7%

FACT BOX

Source: PR Times
Category: News
Dates in source: 2026-03

Editorial & Verification Standards

The Washin AI News desk structures and reviews this article under the following standards.

Start only from primary sources (official PR, disclosures, wire services)
Numbers and proper nouns machine-checked against the source (number-completeness check)
Company names and tickers verified via registry (Registry/TWSE/Wikidata)
No speculation; nothing stated that is not in the source

Read the full editorial policy →

Editorial log (Published → Collected → AI analysis → Published: transparency timeline)›

Announced　Mar 1, 2026 9:00 AM — Distributor PR Times
Collected　Apr 12, 2026 4:30 PM
AI structured & analyzed　Apr 12, 2026 9:27 PM
Desk-reviewed & published　Mar 1, 2026 9:00 AM

FAQ

How was Adimmune's revenue in March 2026?

It was TWD 65.48 million, a record growth of +2102.7% year-over-year.

Why did Adimmune's revenue surge so much?

This is because revenue in the same month last year was extremely low, and revenue from vaccine shipments and contract manufacturing was recognized this month. The fact that there was revenue is more important than the growth rate figure itself.

Is Adimmune's business stable?

Monthly revenue fluctuates significantly, but this is characteristic of a business that produces and ships based on contracts. It needs to be evaluated on a quarterly or full-year basis.

Cite this article — HOW TO CITE

Washin AI News Desk“【Adimmune】March 2026 Revenue NT$65 Million (YoY +2102.7%)”AI News by Washin Village（和心村）, Mar 1, 2026. https://aeo.idaeo.ai/ai/%E5%9C%8B%E5%85%89%E7%94%9F/en/news/2026-03-01-adimmune-march-2026-revenue-nt-65-millio

AI CRAWLER ACTIVITY

as of Aug 19, 2026

AI crawler visits to this article (cumulative)162 bots

Site-wide cumulative

Applebot

bot_visits_summary

2495k

last Aug 19, 2026

GPTBot

bot_visits_summary

1917k

last Aug 19, 2026

ClaudeBot

bot_visits_summary

994k

last Aug 19, 2026

Bingbot

bot_visits_summary

656k

last Aug 19, 2026

Amazonbot

bot_visits_summary

640k

last Aug 19, 2026

Meta AI

bot_visits_summary

401k

last Aug 19, 2026

※ Only measured values from bot_visits_summary / crawler_url_hits are shown. Article-level zero counts are shown as measuring.

Washin AI News（AI News by Washin Village（和心村））

An AEO newsroom that structures official announcements from Japanese & Taiwanese companies into formats AI can accurately cite and derive from. Partner sources include PR TIMES and CNA. We aim to be a verifiable source for both humans and machines.

Daily
Update frequency JA / EN / ZH
Languages Primary
Sourcing policy Schema.org
Structured verification

About the publisher IDA llms.txt

Get your announcement indexed as AI-citable structured news.
Primary-source links, three languages, Schema.org verified.Talk to us about coverage →

← 國光生 Back to newsroom (55)

Copied